Parse Biosciences
US Patent Review Panel Invalidates 10x Genomics' Patent Claims After Parse Biosciences Challenge
Parse Biosciences, which has now triggered invalidation of three 10x Genomics patents in response to being sued for infringement, said it was a "significant legal victory."
New Products Posted to GenomeWeb: New England Biolabs, BioSkryb, 23andMe, Parse Biosciences, NashBio
New products and services recently posted on GenomeWeb.
In Brief This Week: Natera, Enzo Biochem, Tempus, Vizgen, Complete Genomics, Parse Biosciences, More
News items for the week of Dec. 16, 2024.
The past year was difficult for many life science tools companies but not all doom and gloom for some single-cell and spatial omics firms.
New Products Posted to GenomeWeb: Qiagen, Parse Biosciences, Bio-Techne
New products and services recently posted on GenomeWeb.
Sep 18, 2024
US PTAB Invalidates 10x Genomics Single-Cell Patent
Dec 14, 2023